Page last updated: 2024-12-05

lead sulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Lead sulfide (PbS) is a naturally occurring mineral, known as galena. It is a black, crystalline solid with a high refractive index. It is an important semiconductor material with a wide range of applications, including in solar cells, infrared detectors, and thermoelectric devices. It is also used as a pigment in paints and ceramics. Lead sulfide can be synthesized through various methods, including the reaction of lead salts with sulfide ions. Its properties are highly dependent on its crystal structure, impurities, and synthesis conditions. Studies on lead sulfide focus on its electronic, optical, and thermoelectric properties, aiming to optimize its performance for various applications. Lead sulfide is of particular interest due to its tunable band gap, high absorption coefficient, and low cost.'

lead sulfide: surma refers to fine powder-like mascara, applied to conjunctival surfaces of eyes; originally contained antimony sulfide (derived from Urdu word for antimony); recently lead sulfide has been used due to scarcity of antimony; RN given refers to cpd with MF of Pb-S; galena is the principal ore of lead sulfide. Black kohl stone and red-brown kohl stone are widely used in eye cosmetics in the Middle East, Asia and Africa [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14819
MeSH IDM0069861

Synonyms (95)

Synonym
unii-2425d15sym
ec 215-246-6
lead(ii) sulfide
lead monosulfide
p 128
lead sulfide (pbs)
lead(2+) sulfide
p 128 (sulfide)
einecs 215-246-6
c.i. 77640
plumbous sulfide
ccris 1944
natural galena
galena
ci 77640
hsdb 639
p 37 (filter)
natural lead sulfide
lead sulphide
lead(ii) sulfide, 99.9% trace metals basis
lead sulfide
1314-87-0
lead (ii) sulfide
sulfanylidenelead
galena (pbs)
12179-39-4
AKOS015903588
galena, naturally occurring mineral, grains, approximately 0.06-0.19in
lead sulfide candots? quantum dot (pbs core - ~3nm), 10 mg/ml in toluene, 1000nm peak emission
lead(ii) sulfide, pb 82% min.
mfcd00016280
lead sulfide candots? quantum dot (pbs core - ~4.5nm), 10 mg/ml in toluene, 1200nm peak emission
lead sulfide candots? quantum dot (pbs core - ~8nm), 10 mg/ml in toluene, 1600nm peak emission
lead sulfide candots? quantum dot (pbs core - ~6nm), 10 mg/ml in toluene, 1400nm peak emission
J-006010
pbs core-type quantum dots
lead sulfur hollow nanospheres
pbs quantum dots
Q411436
lead sulphide-mpa-cooh quantum dots
lead sulphide qds
lead sulfide quantum dots
indium gallium zinc oxide (igzo) sputtering targets
lead sulphide-peg-nh quantum dots
lead sulphide-peg-cooh quantum dots
lead sulphide quantum dots
lead sulfide hollow nanospheres
((pb s)1.18 ti s2).8475
pbs-peg-cooh quantum dots-850 nm
pbs core-type quantum dots-1000 nm
pbs quantum dots-1000 nm
pbs quantum dots-700 nm
pbs-peg-nh2 quantum dots-1030 nm
pbs led quantum dots-1300 nm
pbs-peg-cooh quantum dots-1120 nm
pbs quantum dots-800 nm
pbs quantum dots-1600 nm
pbs core-type quantum dots-1400 nm
pbs-peg-nh2 quantum dots-850 nm
pbs quantum dots-1200 nm
pbs core-type quantum dots-1500 nm
pbs-peg-cooh quantum dots-920 nm
pbs-peg-cooh quantum dots
pbs-mpa-cooh quantum dots-1120 nm
pbs core-type quantum dots-900 nm
pbs-mpa-cooh quantum dots-920 nm
pbs-mpa-cooh quantum dots-1030 nm
pbs-mpa quantum dots-850 50nm
pbs quantum dots-1500 nm
pbs core-type quantum dots-1100 nm
pbs-peg-nh2 quantum dots-1120 nm
pbs-peg-nh2 quantum dots-920 nm
pbs quantum dots-1400 nm
pbs quantum dot solar cells-1100 nm
lead sulfide quantum dots-900 nm
BAA31487
lead sulfide stremdots cent quantum dot (pbs core - ~3nm), 10 mg/ml in toluene, 1000nm peak emission
infiq?-r-hp-qds, lead sulphide quantum dots, 1350 nm absorption peak, 50 mg/ml in octane
infiq?-r-hp-qds, lead sulphide quantum dots, 1650 nm absorption peak, 50 mg/ml in octane
infiq?-r-hp-qds, lead sulphide quantum dots, 2000 nm absorption peak, 50 mg/ml in octane
infiq?-r-hp-qds, lead sulphide quantum dots, 1250 nm absorption peak, 50 mg/ml in octane
infiq?-r-hp-qds, lead sulphide quantum dots, 1850 nm absorption peak, 50 mg/ml in octane
infiq?-r-hp-qds, lead sulphide quantum dots, 1550 nm absorption peak, 50 mg/ml in octane
pbs quantum dots, fluorescence: lambdaem 1000nm, 10 mg/ml in toluene
pbs quantum dots, fluorescence: lambdaem 900nm, 10 mg/ml in toluene
pbs quantum dots, oleic acid coated, fluorescence: lambdaem 1200nm, 10 mg/ml in toluene
pbs quantum dots, fluorescence: lambdaem 1500nm, 10 mg/ml in toluene
pbs quantum dots, fluorescence: lambdaem 1200nm, 10 mg/ml in toluene
pbs quantum dots, oleic acid coated, fluorescence: lambdaem 1300nm, 10 mg/ml in toluene
pbs quantum dots, fluorescence: lambdaem 1100nm, 10 mg/ml in toluene
pbs quantum dots, oleic acid coated, fluorescence: lambdaem 1600nm, 10 mg/ml in toluene
pbs quantum dots, oleic acid coated, fluorescence: lambdaem 1400nm, 10 mg/ml in toluene
pbs quantum dots, fluorescence: lambdaem 1600nm, 10 mg/ml in toluene
pbs quantum dots, fluorescence: lambdaem 1400nm, 10 mg/ml in toluene
pbs quantum dots, oleic acid coated, fluorescence: lambdaem 1000nm, 10 mg/ml in toluene

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"A sensitive and selective on chip magnetic immunoassay method, based on a sandwich-type immunoreaction with PbS nanoparticle (NPs) labels in combination with electrothermal vaporization-inductively coupled plasma mass spectrometry (ETV-ICP-MS), was proposed for the determination of carcinoembryonic antigen (CEA)."( Nanoparticle labelling-based magnetic immunoassay on chip combined with electrothermal vaporization-inductively coupled plasma mass spectrometry for the determination of carcinoembryonic antigen in human serum.
Chen, B; He, M; Hu, B; Jiang, P; Peng, H; Zhang, X, 2011
)
0.37

Bioavailability

ExcerptReferenceRelevance
" Consequently, the hazard of lead in soils appears to be site-specific and influenced by bioavailability; the bioavailability of galena tailings to humans is low."( Blood lead surveys of communities in proximity to lead-containing mill tailings.
Danse, IH; Garb, LG; Moore, RH, 1995
)
0.29
"An animal model using rats was developed to initiate investigations on the bioavailability of different sources of environmental lead."( Comparison of lead bioavailability in F344 rats fed lead acetate, lead oxide, lead sulfide, or lead ore concentrate from Skagway, Alaska.
Dieter, MP; Jeffcoat, RA; Matthews, HB; Moseman, RF, 1993
)
0.51
"A 44-day dosed feed study was performed to compare the bioavailability of lead from contaminated soil versus two lead salts and the effect of soil on gastrointestinal absorption of ingested lead."( Comparative absorption of lead from contaminated soil and lead salts by weanling Fischer 344 rats.
Dill, JA; Freeman, GB; Johnson, JD; Kurtz, PJ; Matthews, HB; Parham, F, 1996
)
0.29
" If lead bioavailability is related to its solubility as determined through sequential extraction, the health hazards associated with lead exposure may be appreciably enhanced in the blast and dross furnace processes."( Chemical speciation of lead dust associated with primary lead smelting.
Spear, TM; Stanisich, N; Svee, W; Vincent, JH, 1998
)
0.3
" It was observed that XRD was incapable of detecting pyromorphite, the hopeful endpoint of the immobilization strategy for reduced Pb bioavailability in our studies."( Determining speciation of Pb in phosphate-amended soils: method limitations.
Allen, D; Lescano, NV; Ryan, JA; Scheckel, KG, 2005
)
0.33

Dosage Studied

ExcerptRelevanceReference
"A 44-day dosed feed study was performed to compare the bioavailability of lead from contaminated soil versus two lead salts and the effect of soil on gastrointestinal absorption of ingested lead."( Comparative absorption of lead from contaminated soil and lead salts by weanling Fischer 344 rats.
Dill, JA; Freeman, GB; Johnson, JD; Kurtz, PJ; Matthews, HB; Parham, F, 1996
)
0.29
"The authors propose to consider as hormesis phenomenon not only a realization of the Arndt-Schulze rule but any non-monotonic dose-response relationship for a certain outcome that is characterized by changing direction of a response between adjacent ranges of doses of an initiator of this response, the number of such ranges being two or more."( On an extended understanding of the term "hormesis" for denoting alternating directions of the organism's response to increasing adverse exposures.
Bushueva, TV; Gurvich, VB; Katsnelson, BA; Klinova, SV; Minigalieva, IA; Panov, VG; Privalova, LI; Sutunkova, MP, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
galena oxidation05

Research

Studies (277)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (6.86)18.7374
1990's16 (5.78)18.2507
2000's66 (23.83)29.6817
2010's158 (57.04)24.3611
2020's18 (6.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 63.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index63.47 (24.57)
Research Supply Index5.66 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index105.14 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (63.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.71%)5.53%
Reviews8 (2.83%)6.00%
Case Studies6 (2.12%)4.05%
Observational0 (0.00%)0.25%
Other267 (94.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]